Pharmacological properties
Pharmacodynamics. gelmintoks — protivogelmintny medicament which is active concerning enterobius vermicularis, ascaris lumbricoides, ancylostoma duodenale, necator americanus. gelmintoks blocks a neuromuscular system, causing paralysis of helminths owing to what they under the influence of a vermicular movement are brought from an organism with a stake. gelmintoks it is active against sensitive puberal and immature forms. larvae which migrate through fabrics are insensitive to drug.
Pharmacokinetics. Intra intestinal absorption of medicament minimum owing to insolubility of Pyrantelum of the embonat. Concentration of medicament in blood plasma is insignificant — from 0.05 to 0.13 mg/ml. The main absorption which is estimated by indicators of not changed substance and metabolites in urine — 3.8%. The main metabolite is N-methyl-1.3-propandiamin which concentration in urine of 1.2-4.6%. More than 93% of medicament are removed in not changed view with a stake.
Indication
Enterobiosis, ascaridosis, ankilostomidoz, necatoriasis.
Use
Suspension. in an enterobiosis, an ascaridosis the average dose makes 10–12 mg/kg of body weight on 1 reception, that is:
- to children aged from 6 months — 1 measured spoon of suspension on 10 kg of body weight in one step;
- adult with body weight to 75 kg — 6 measured spoons on one reception;
- adult with the body weight of 75 kg — 8 measured spoons on one reception.
At treatment of an enterobiosis for the purpose of improvement of effect recommends accurate observance of rules of personal hygiene (especially to children) and a repeated course of treatment in 3 weeks after previous.
byAt an ankilostomidoza in case of a heavy invasion or in endemic zones appoint in a dose 20 mg/kg of body weight a day in 1–2 receptions for 2–3 days, that is:
- children aged from 6 months — 2 measured spoons of suspension on 10 kg of body weight a day;
- adult with body weight to 75 kg — 12 measured spoons a day;
- 75 kg, adult with body weight — 16 measured spoons a day.
in case of an invasion of Ancylostoma duodenale which arose in not endemic zones enough dose of 10 mg/kg of body weight once can be li>.
Adult medicament in the form of tablets is more reasonable to appoint.
Tablet. In an enterobiosis, an ascaridosis: to children at the age of 6–18 years — 1 tablet (125 mg) on 10 kg of body weight adult with body weight to 75 kg — 6 tablets on 125 mg or 3 tablets on 250 mg. Adults with body weight from 75 kg — 4 tablets on 250 mg.
At an ankilostomidoza and a necatoriasis the same dosing or, at severe forms, on 20 mg/kg/days in 1 or 2 receptions for 2–3 days.
byAt treatment of an enterobiosis for the purpose of improvement of effect recommends strict observance of rules of personal hygiene, especially to children; and also repeated administration of medicament in 4 weeks after the carried-out treatment.
Contraindication
Hypersensitivity to medicament components, a liver failure.
Side effects
from central nervous system: dizziness, drowsiness, insomnia, headache;
from skin and hypodermic cellulose: rash, urticaria;
from a GIT: anorexia, vomiting, spasms in a stomach, diarrhea, tenesmus;
gepatobiliarny disturbances: increase in level of liver enzymes;
other: weakness, increased fatigue.
Special instructions needs to appointGelmintoks by
with care the patient with abnormal liver functions. gelmintoks always accept once, irrespective of meal and time of day; there is no need to apply depletive or to abstain from meal.
should take the Drug at the same time to all family members.
toFor prevention of repeated infection recommends accurate observance of rules of personal hygiene.
Use during pregnancy and feeding by a breast. In pilot studies the teratogenic influence of Pyrantelum on a fruit is not revealed, in clinical practice it was not reported about any side effects at medicament treatment of pregnant women. During pregnancy and feeding by a breast medicament is used according to strict indications after careful assessment of a ratio advantage for woman/risk for a fruit (child) which is determined by the doctor, and by strict observance of recommendations about dosing.
Children. The Ability to influence speed of response at control of vehicles or work with other mechanisms is appointed to children aged from 6 months
. Dizziness, drowsiness and weakness which sometimes note at treatment by Gelmintoks can affect speed of response at control of vehicles and work with cars and difficult mechanisms.
Interaction
not to use medicament together with levamisole as at simultaneous use the potentiation of toxicity of levamisole and increase in level of theophylline in blood plasma is possible. not to apply with piperazin which is an antagonist of protivogelmintny effect of Pyrantelum.
Overdoseanorexia, nausea, vomiting, diarrhea, an ataxy, however in connection with the minimum quantities of Pyrantelum which is adsorbed Are possible
, even at considerable overdose seldom there are symptoms of intoxication. gastric lavage owing to lack of specific antidote is recommended.
Preventive measures: control of function of a respiratory and cardiovascular system.
Storage conditions
At a temperature not above 25 °C.
Characteristics | |
Active ingredients | Pyrantelum |
Amount of active ingredient | 250 mg |
Applicant | Innotech |
Code of automatic telephone exchange | P02CC01 Pyrantelum |
Interaction with food | It doesn't matter |
Light sensitivity | Not sensitive |
Market status | The branded generic |
Origin | Chemical |
Prescription status | Without prescription |
Primary packing | blister |
Producer | INNOTERA SHUZI |
Quantity in packing | 3 tablets |
Release form | tablets for internal use |
Route of administration | Oral |
Sign | Import |
Storage temperature | from 5 °C to 25 °C |
Trade name | Gelmintoks |
Gelmintoks tab. of p/o of 250 mg No. 3
- Product Code: 182936
- In Stock
- Ready to ship
-
$18.20